Circulation · 1980 · 49 citations · 8 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmaceutical CareAntithrombotic TherapyPlatelet PhysiologyThromboembolism PreventionThrombosisThrombosis ManagementThrombosis PreventionHalf-life MeasurementRecurrent ThromboembolismRheumatic Mitral StenosisRheumatic Valvular DiseaseThromboprophylaxis In Medical Inpatients
Thromboembolism complicates the course of patients with rheumatic heart disease (mitral stenosis) and platelet survival time has been shown to be shortened in patients with a history of thromboem- bolism; sulfinpyrazone has been shown to increase platelet survival in these patients. A prospective, blinded trial of sulfinpyrazone therapy in patients with rheumatic heart disease has been completed. One hundred fiftyfour of 186 patients had shortened platelet survival (chromium-51 labeling of autologous platelets) on enroll- ment and were randomized to treatment with either sulfinpyrazone or placebo. Thirty-two patients with ini- tially normal platelet survival were neither randomized nor treated. New thromboembolism occurred in 19 patients during 4 years of observation: two received sulfinpyrazone, 16 received placebo (X2 = 12.75,p < 0.01) and one had normal initial platelet survival time. Sulfinpyrazone increased platelet survival time (control 2.5 0.04 days [average SEMI; normal half life 3.7 0.03 days; 1 year 2.8 0.04 days; n = 78) relative to placebo (control 2.6 0.04 days; 1 year 2.5 0.05 days; n = 76, p < 0.01). The results of this trial confirm earlier work suggesting that platelet survival time is frequently shortened in patients with rheumatic heart dis- ease, and that sulfinpyrazone increases platelet survival. Sulfinpyrazone appears to decrease thromboembolism in patients with rheumatic mitral stenosis.
8
Platelet and Fibrinogen Consumption in Man
Laurence A. Harker, Sherrill J. Slichter · New England Journal of Medicine · 1972 · 494 citations
Medicine, Hematology, Hemostasis +9
An Appreciation of Mitral Stenosis--I
Effect of Anticoagulant and ABO Incompatibility on Recovery of Transfused Human Platelets
Richard H. Aster · Blood · 1965 · 218 citations · Full text
Medicine, Hematology, Hemostasis +12
Arteriovenous-Shunt Thrombosis
A. Kaegi, G F Pineo, Akira Shimizu et al. · New England Journal of Medicine · 1974 · 147 citations